The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis

The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2001-12, Vol.33 (11), p.1824-1833
Hauptverfasser: Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W., Stevens, D. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1833
container_issue 11
container_start_page 1824
container_title Clinical infectious diseases
container_volume 33
creator Perfect, J. R.
Cox, G. M.
Lee, J. Y.
Kauffman, C. A.
de Repentigny, L.
Chapman, S. W.
Morrison, V. A.
Pappas, P.
Hiemenz, J. W.
Stevens, D. A.
description The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.
doi_str_mv 10.1086/323900
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72258383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4482900</jstor_id><oup_id>10.1086/323900</oup_id><sourcerecordid>4482900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-c51edf8eb03e82200a9fcb197ecab8c9bd6823318053e94c2dcf464d8c5503523</originalsourceid><addsrcrecordid>eNqF0M1u1DAUBWALUdFS4AkqFBZ0l-LfxGE3jEqnahGLDhJiYxznpnXxjINvUtG3b0YZddQF6srWPZ-urUPIO0ZPGNXFJ8FFRekLcsCUKPNCVezleKdK51ILvU9eI95Sypim6hXZZ6yoOK_EAfm9vIHsfNVZ12exzeZD6Ic0TjAG2_u43gxn2EG69iEMmF114Dzg52yWLSJ2vrch_2IRmuxqSHdw_8RH9PiG7LU2ILzdnofkx9fT5XyRX34_O5_PLnMnOetzpxg0rYaaCtCcU2qr1tWsKsHZWruqbgrNhdj8X0AlHW9cKwvZaKcUFYqLQ3I87e1S_DsA9mbl0UEIdg1xQFNyrsYmxLOQaSlLWsoddCkiJmhNl_zKpnvDqNmUbqbSR_h-u3GoV9Ds2LblEXzcAovOhjbZtfO4c5JJwWgxug-Ti0P3_8eOJnOLfUyPSkrNpzifYo89_HuMbfpjilKUyix-_jJlQb-dLeiFWYoHZsCqPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18447074</pqid></control><display><type>article</type><title>The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Perfect, J. R. ; Cox, G. M. ; Lee, J. Y. ; Kauffman, C. A. ; de Repentigny, L. ; Chapman, S. W. ; Morrison, V. A. ; Pappas, P. ; Hiemenz, J. W. ; Stevens, D. A.</creator><creatorcontrib>Perfect, J. R. ; Cox, G. M. ; Lee, J. Y. ; Kauffman, C. A. ; de Repentigny, L. ; Chapman, S. W. ; Morrison, V. A. ; Pappas, P. ; Hiemenz, J. W. ; Stevens, D. A. ; Mycoses Study Group ; the Mycoses Study Group</creatorcontrib><description>The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/323900</identifier><identifier>PMID: 11692293</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Allergic bronchopulmonary aspergillosis ; Aspergillosis ; Aspergillosis - diagnosis ; Aspergillosis - microbiology ; Aspergillosis - mortality ; Aspergillus ; Aspergillus - isolation &amp; purification ; Biological and medical sciences ; Chronic diseases ; Cross Infection - diagnosis ; Cross Infection - microbiology ; Cross Infection - mortality ; Epidemiology ; Female ; Fungal infections ; General aspects ; Health outcomes ; Humans ; Infections ; Infectious diseases ; Lung diseases ; Major Articles ; Male ; Medical sciences ; Middle Aged ; Mycoses ; Opportunistic Infections - diagnosis ; Opportunistic Infections - microbiology ; Opportunistic Infections - mortality ; Predisposing factors ; Risk Factors</subject><ispartof>Clinical infectious diseases, 2001-12, Vol.33 (11), p.1824-1833</ispartof><rights>Copyright 2001 The Infectious Diseases Society of America</rights><rights>2001 by the Infectious Diseases Society of America 2001</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-c51edf8eb03e82200a9fcb197ecab8c9bd6823318053e94c2dcf464d8c5503523</citedby><cites>FETCH-LOGICAL-c421t-c51edf8eb03e82200a9fcb197ecab8c9bd6823318053e94c2dcf464d8c5503523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4482900$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4482900$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14143106$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11692293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perfect, J. R.</creatorcontrib><creatorcontrib>Cox, G. M.</creatorcontrib><creatorcontrib>Lee, J. Y.</creatorcontrib><creatorcontrib>Kauffman, C. A.</creatorcontrib><creatorcontrib>de Repentigny, L.</creatorcontrib><creatorcontrib>Chapman, S. W.</creatorcontrib><creatorcontrib>Morrison, V. A.</creatorcontrib><creatorcontrib>Pappas, P.</creatorcontrib><creatorcontrib>Hiemenz, J. W.</creatorcontrib><creatorcontrib>Stevens, D. A.</creatorcontrib><creatorcontrib>Mycoses Study Group</creatorcontrib><creatorcontrib>the Mycoses Study Group</creatorcontrib><title>The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.</description><subject>Allergic bronchopulmonary aspergillosis</subject><subject>Aspergillosis</subject><subject>Aspergillosis - diagnosis</subject><subject>Aspergillosis - microbiology</subject><subject>Aspergillosis - mortality</subject><subject>Aspergillus</subject><subject>Aspergillus - isolation &amp; purification</subject><subject>Biological and medical sciences</subject><subject>Chronic diseases</subject><subject>Cross Infection - diagnosis</subject><subject>Cross Infection - microbiology</subject><subject>Cross Infection - mortality</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fungal infections</subject><subject>General aspects</subject><subject>Health outcomes</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lung diseases</subject><subject>Major Articles</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycoses</subject><subject>Opportunistic Infections - diagnosis</subject><subject>Opportunistic Infections - microbiology</subject><subject>Opportunistic Infections - mortality</subject><subject>Predisposing factors</subject><subject>Risk Factors</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0M1u1DAUBWALUdFS4AkqFBZ0l-LfxGE3jEqnahGLDhJiYxznpnXxjINvUtG3b0YZddQF6srWPZ-urUPIO0ZPGNXFJ8FFRekLcsCUKPNCVezleKdK51ILvU9eI95Sypim6hXZZ6yoOK_EAfm9vIHsfNVZ12exzeZD6Ic0TjAG2_u43gxn2EG69iEMmF114Dzg52yWLSJ2vrch_2IRmuxqSHdw_8RH9PiG7LU2ILzdnofkx9fT5XyRX34_O5_PLnMnOetzpxg0rYaaCtCcU2qr1tWsKsHZWruqbgrNhdj8X0AlHW9cKwvZaKcUFYqLQ3I87e1S_DsA9mbl0UEIdg1xQFNyrsYmxLOQaSlLWsoddCkiJmhNl_zKpnvDqNmUbqbSR_h-u3GoV9Ds2LblEXzcAovOhjbZtfO4c5JJwWgxug-Ti0P3_8eOJnOLfUyPSkrNpzifYo89_HuMbfpjilKUyix-_jJlQb-dLeiFWYoHZsCqPQ</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>Perfect, J. R.</creator><creator>Cox, G. M.</creator><creator>Lee, J. Y.</creator><creator>Kauffman, C. A.</creator><creator>de Repentigny, L.</creator><creator>Chapman, S. W.</creator><creator>Morrison, V. A.</creator><creator>Pappas, P.</creator><creator>Hiemenz, J. W.</creator><creator>Stevens, D. A.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20011201</creationdate><title>The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis</title><author>Perfect, J. R. ; Cox, G. M. ; Lee, J. Y. ; Kauffman, C. A. ; de Repentigny, L. ; Chapman, S. W. ; Morrison, V. A. ; Pappas, P. ; Hiemenz, J. W. ; Stevens, D. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-c51edf8eb03e82200a9fcb197ecab8c9bd6823318053e94c2dcf464d8c5503523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Allergic bronchopulmonary aspergillosis</topic><topic>Aspergillosis</topic><topic>Aspergillosis - diagnosis</topic><topic>Aspergillosis - microbiology</topic><topic>Aspergillosis - mortality</topic><topic>Aspergillus</topic><topic>Aspergillus - isolation &amp; purification</topic><topic>Biological and medical sciences</topic><topic>Chronic diseases</topic><topic>Cross Infection - diagnosis</topic><topic>Cross Infection - microbiology</topic><topic>Cross Infection - mortality</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fungal infections</topic><topic>General aspects</topic><topic>Health outcomes</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lung diseases</topic><topic>Major Articles</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycoses</topic><topic>Opportunistic Infections - diagnosis</topic><topic>Opportunistic Infections - microbiology</topic><topic>Opportunistic Infections - mortality</topic><topic>Predisposing factors</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perfect, J. R.</creatorcontrib><creatorcontrib>Cox, G. M.</creatorcontrib><creatorcontrib>Lee, J. Y.</creatorcontrib><creatorcontrib>Kauffman, C. A.</creatorcontrib><creatorcontrib>de Repentigny, L.</creatorcontrib><creatorcontrib>Chapman, S. W.</creatorcontrib><creatorcontrib>Morrison, V. A.</creatorcontrib><creatorcontrib>Pappas, P.</creatorcontrib><creatorcontrib>Hiemenz, J. W.</creatorcontrib><creatorcontrib>Stevens, D. A.</creatorcontrib><creatorcontrib>Mycoses Study Group</creatorcontrib><creatorcontrib>the Mycoses Study Group</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perfect, J. R.</au><au>Cox, G. M.</au><au>Lee, J. Y.</au><au>Kauffman, C. A.</au><au>de Repentigny, L.</au><au>Chapman, S. W.</au><au>Morrison, V. A.</au><au>Pappas, P.</au><au>Hiemenz, J. W.</au><au>Stevens, D. A.</au><aucorp>Mycoses Study Group</aucorp><aucorp>the Mycoses Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2001-12-01</date><risdate>2001</risdate><volume>33</volume><issue>11</issue><spage>1824</spage><epage>1833</epage><pages>1824-1833</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>11692293</pmid><doi>10.1086/323900</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2001-12, Vol.33 (11), p.1824-1833
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_72258383
source Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Allergic bronchopulmonary aspergillosis
Aspergillosis
Aspergillosis - diagnosis
Aspergillosis - microbiology
Aspergillosis - mortality
Aspergillus
Aspergillus - isolation & purification
Biological and medical sciences
Chronic diseases
Cross Infection - diagnosis
Cross Infection - microbiology
Cross Infection - mortality
Epidemiology
Female
Fungal infections
General aspects
Health outcomes
Humans
Infections
Infectious diseases
Lung diseases
Major Articles
Male
Medical sciences
Middle Aged
Mycoses
Opportunistic Infections - diagnosis
Opportunistic Infections - microbiology
Opportunistic Infections - mortality
Predisposing factors
Risk Factors
title The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A39%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20of%20Culture%20Isolation%20of%20Aspergillus%20Species:%20A%20Hospital-Based%20Survey%20of%20Aspergillosis&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Perfect,%20J.%20R.&rft.aucorp=Mycoses%20Study%20Group&rft.date=2001-12-01&rft.volume=33&rft.issue=11&rft.spage=1824&rft.epage=1833&rft.pages=1824-1833&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/323900&rft_dat=%3Cjstor_proqu%3E4482900%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18447074&rft_id=info:pmid/11692293&rft_jstor_id=4482900&rft_oup_id=10.1086/323900&rfr_iscdi=true